{
  "@context": "https://frontierpicks.com/schemas/dossier.v1.json",
  "ticker": "SG",
  "name": "Sweetgreen, Inc.",
  "url": "https://frontierpicks.com/dossiers/SG/",
  "json_url": "https://frontierpicks.com/dossiers/SG.json",
  "status": "DORMANT",
  "current_conviction": "LOW",
  "graded_conviction": null,
  "archetype": {
    "code": "a6",
    "n": 6
  },
  "current_thesis": "The turnaround narrative was retracted by management on 2026-08-06 and repriced by eight desks into a $5.00–$8.50 target band. What has run since — $6.28 on 2026-08-14 to $6.99 on 2026-08-21 — is a ~24.5%-shorted float drifting up in a catalyst vacuum, with no company event scheduled before the ~November Q3 print and price now above six of the eight post-print targets.",
  "invalidation_trigger": "A weekly close below $6.00 gives back the entire post-guide-down recovery leg and re-opens the 2026-08-13 area near $5.82. Secondarily, the ~2026-08-26 short-interest publication showing the 22.889M-share base materially reduced without price clearing $7.40 removes the mechanical bid, with no company event before the ~2026-11-05 Q3 print.",
  "catalyst_date": "2026-08-26",
  "outcome": "OPEN",
  "outcome_date": null,
  "invalidation_fired": null,
  "themes": [
    "consumer-discretionary-rotation",
    "squeeze-momentum-setups",
    "oil-energy-geopolitical"
  ],
  "tags": [],
  "sources": [],
  "notes": [
    "Dual-class structure: super-voting Class B held by the founder group concentrates control and mutes activist or takeover pressure on Class A holders.",
    "GAAP EPS headlines here are noisy (prior-year divestiture gains). The tracked lines are comps, restaurant-level margin and adjusted EBITDA — FY26 guided to a $23–27M EBITDA loss.",
    "Taylor Farms de Mexico, the cyclospora source, also supplies McDonald's, Chipotle, Walmart, Target, Costco and Kroger; the leafy-green demand overhang is sector-wide.",
    "SEC risk disclosures name cyclospora explicitly and concede fresh in-restaurant prep carries greater contamination exposure than commissary-based competitors. Recurrence is a structural tail risk.",
    "High-beta mechanics: beta ~2.16 with 62 daily moves greater than 5% in the trailing year on a sub-$1B market cap. Gap risk is a permanent feature of this name.",
    "The Point72 13G (2026-05-15) reported 6,622,017 shares, of which 2,713,600 are issuable on call options (~41%) — optionality that can expire, not committed equity."
  ],
  "body_markdown": "\n- # SG — Sweetgreen, Inc.\n\n## Current Thesis\nThe narrative an investor was buying in June and July — an exogenous, one-quarter food-safety dent sitting on top of a self-help margin recovery — was withdrawn by the company that issued it on 2026-08-06. FY26 comparable sales went to −8.0%/−7.0% from −4%/−2%, restaurant-level margin to 10.5–11.0% from 14.2–14.7%, and adjusted EBITDA to a loss of $23–27M from a guided $1–6M profit. Eight desks reset targets into a $5.00–$8.50 band over the following week.\n\nWhat has happened since the last update is price, not information. The shares closed at $6.99 on 2026-08-21, a gain of 6.23% on the day from a $6.58 prior close (stockanalysis.com quote data as of 2026-08-22), against a 2026-08-14 close of $6.28. The only dated company items in that window are a fourth Sweetlane drive-thru opening in McLean, Virginia on 2026-08-20 and a limited-edition Fishwife tinned-fish Niçoise salad on 2026-08-11. Neither carries a P&L number. The inference: an approximately 24.5%-shorted float is drifting higher in a catalyst vacuum, with no company-scheduled event before the Q3 print in early November.\n\nThe narrative is **dead**. The turnaround narrative was retracted by management on 2026-08-06 and priced out by brokers on 2026-08-07 and 2026-08-10. What trades now is positioning mechanics on a $832.10M market cap (119.04M shares outstanding, stockanalysis.com as of 2026-08-22), and positioning is not a story that compounds — it resolves.\n\n## Bull Case\n- The guide-down is quantified and therefore checkable. Management sized cyclosporiasis at 200–300bps of FY comparable sales and $7–10M of adjusted EBITDA on the 2026-08-06 call, with a 600–700bps comp drag assumed in Q3 alone. A bar that front-loads the worst quarter can be cleared if traffic normalizes faster than the assumption.\n- Cash and equivalents were $142.6M at 2026-06-28, against a guided FY26 adjusted EBITDA loss of $23–27M. On the guide as given, the fiscal year is funded without an equity raise, though capex for roughly 13 net new restaurants is an additional draw.\n- Short interest was last reported at 22.889M shares, 24.53% of float, 5.78 days to cover (exchange data reported mid-July 2026). No earnings event exists to force a resolution before ~November, which cuts both ways but leaves the crowded side of the book exposed to drift.\n- Digital was 66.3% of Q2 revenue versus 60.8% a year earlier (2026-08-06 release) — channel mix kept shifting while traffic fell.\n- Two desks kept constructive targets above the last close: Citi at $8.00 (Buy) and Oppenheimer at $8.50 (Outperform), both set 2026-08-07.\n- Unit and menu activity did not stop: the McLean Sweetlane on 2026-08-20 was the fourth drive-thru format location.\n\n## Bear Case\n- FY26 adjusted EBITDA guidance flipped from +$1–6M to −$27M/−$23M in one quarter (2026-08-06). Profitability is off the table this fiscal year.\n- Q2 comps came in at −6.2% against an FY guide of −8.0%/−7.0%, which implies a second half worse than the first.\n- Restaurant-level profit margin was 13.1% in Q2 versus 18.9% a year earlier, before the guided step down to 10.5–11.0%. Q2 adjusted EBITDA was $(0.2)M against $6.4M; net loss $(26.3)M against $(23.2)M.\n- Six of the eight post-print targets sit below the 2026-08-21 close of $6.99: TD Cowen $5.00 (Hold), DA Davidson $5.50 (Neutral, 2026-08-10), Wells Fargo $6.00 (Equal-Weight), Bank of America $6.40 (cut from $8.00 following the print), UBS $6.50 (Neutral) and RBC $6.50 (Outperform, reiterated 2026-08-11).\n- Net new openings guided to about 13 for FY26, with 2 opened in Q2. The revenue line has no unit offset while comps contract.\n- Demand weakness is sector-wide, not company-specific: coverage on 2026-08-08 reported salad-chain traffic falling as consumers avoided greens. That removes the \"share-shift winner\" framing and makes recovery dependent on category behaviour SG does not control.\n- Management declined to time the recovery — \"the pace and timing of recovery remain uncertain\" (2026-08-06 release).\n\n## Setup & Price Structure\nReference close 2026-08-21: $6.99. RSI(14) at 63.6 — recovered off the post-print washout, short of an overbought reading. The shares are 31.5% below the 52-week high of $10.21 on the split/dividend-adjusted series, and the three-month price change is −28.5%. Raw trailing-year range reported by stockanalysis.com is $4.49–$10.63.\n\nThe structure is a V off a mid-August trough. Quote data for 2026-08-13 showed the shares near $5.82; the 2026-08-14 close was $6.28, and 2026-08-21 closed at $6.99. The single largest day of that leg, 2026-08-21 at +6.23%, carried no company announcement — the last dated item was the prior day's Virginia opening. Overhead, the $7.40 area is the shelf where the July exoneration rally stalled before the print, and it is the first level that would reconnect price to the pre-guide-down structure. Below, the $5.80–$6.00 zone is where the post-print base formed.\n\nCrowding and positioning observables, stated as observables:\n- 24.53% of float short as of the mid-July report, 5.78 days to cover. No settlement-date update has been published since the guide-down.\n- Price is above six of eight post-print targets, so the analyst community is a source of downgrade risk rather than a marginal bid at this level.\n- Daily Political reported on 2026-08-21 that the CFO sold $93,354.93 and the COO $29,863.89 of stock. These are small, likely vest-related dispositions; the observable is that executive selling, not buying, is what printed into the bounce.\n- Beta of roughly 2.16 with 62 daily moves greater than 5% in the trailing year on a sub-$1B market cap. Gap risk is a permanent feature.\n- No company-scheduled event inside 30 days. The only dated items are short-interest publications.\n\n## Catalyst Calendar (next 30 days)\n- **~2026-08-26 (est.)** — Short interest published for the 2026-08-14 settlement date. First positioning read spanning the 2026-08-06 guide-down.\n- **~2026-09-10 (est.)** — Short interest for the 2026-08-31 settlement date. Second consecutive datapoint across a window with no company news.\n- **No company event scheduled inside 30 days.** Q3 FY26 results are expected ~2026-11-05 (est.), the quarter management pre-loaded with a 600–700bps outbreak comp drag.\n- Ongoing, undated: any CDC or FDA update expanding the Taylor Farms de Mexico traceback would re-open the leafy-green demand overhang across the category.\n\n## What Would Change Our Mind\nThe structure that matters is the base built between 2026-08-13 and 2026-08-14 around $5.80–$6.28. Losing it would say the bounce was mechanical exhaust rather than accumulation, and would put price back at post-outbreak lows with no earnings event to arrest it for roughly ten weeks. Concretely: a weekly close below $6.00 gives back the entire post-guide-down recovery leg.\n\nTwo non-price conditions would carry equal weight. First, the ~2026-08-26 and ~2026-09-10 short-interest publications showing the 22.889M-share base materially reduced without price clearing $7.40 — that removes the main mechanical bid and leaves a name whose own guidance calls for an EBITDA loss. Second, the ~2026-11-05 Q3 print landing at or below the guided −8.0% comp assumption with restaurant-level margin under 10.5% would confirm a brand problem rather than a demand shock, and would make a second guide-down the base case rather than a risk.\n\nThe reverse — what would restore a narrative leg — is narrower: a weekly close above $7.40 with short interest still above roughly 20% of float, plus a Q3 comp print inside the guided range. Absent both, the case is arithmetic on a reset guide.\n\n## Correlation Notes\n- **Fast-casual comp cycle.** CAVA and Chipotle are the read-across names for whether the traffic problem is category-wide or company-specific; a CAVA print preview circulated 2026-08-11. SG's own Q2 comp of −6.2% is not decomposable into outbreak versus brand without a peer baseline.\n- **Leafy-green supply chain.** Taylor Farms de Mexico, the cyclospora source identified in the 2026-07-17 FDA traceback, also supplies McDonald's, Chipotle, Walmart, Target, Costco and Kroger. The demand overhang reported on 2026-08-08 is a category effect, so SG trades with a food-safety headline it did not cause and cannot fix.\n- **High-short-interest small-cap basket.** With beta around 2.16 and a 24.5% short float, day-level moves like 2026-08-21's +6.23% on no company news are more consistent with basket and positioning flow than with name-specific repricing. That inference is not directly observable and would be contradicted if a dated company or analyst item surfaces for that session.\n- **Consumer discretionary rotation.** A sub-$1B restaurant name guiding to an EBITDA loss is a rate- and risk-appetite proxy; the recovery leg since 2026-08-14 coincides with no fundamental change at the company.",
  "first_seen": "2026-05-22",
  "last_analyzed": "2026-08-23T16:53:48+00:00",
  "last_synthesized": "2026-08-23",
  "last_update_source": "watchlist_research",
  "license": "Content © FrontierPicks. Cite the canonical URL."
}